Журнал микробиологии, эпидемиологии и иммунобиологии. 2021; 98: 588-596
Эпидемиологическая характеристика инфекций Campylobacter в странах с высоким уровнем дохода: систематический обзор
https://doi.org/10.36233/0372-9311-167Аннотация
Введение. Campylobacter — наиболее частая бактериальная причина болезней пищевого происхождения в странах с высоким уровнем доходов. В отличие от других инфекционных заболеваний, количество случаев Campylobacter увеличилось в развитых странах за последние 10 лет. Систематический обзор был проведён для выявления факторов, способствующих распространению инфекции Campylobacter в развитых странах, и оценки её по возрасту, полу, географии и сезону.
Материалы и методы. Обзор ограничен исследованиями, опубликованными на английском языке за 2010-2021 гг. В обзор были включены восемь общенациональных эпиднадзора и когортных исследований на основе регистров, которые соответствовали критериям отбора.
Результаты. В то время как самая высокая заболеваемость Campylobacter была зарегистрирована среди детей раннего возраста, живущих в сельской местности, самое большое количество случаев Campylobacter среди взрослых было зарегистрировано в городских условиях. Тем не менее больше всего страдают дети и пожилые люди, а уровень заболеваемости выше у мужчин, чем у женщин, причём пик заболеваемости приходится на каждое лето.
Заключение. Инфекция Campylobacter представляет собой проблему для общественного здравоохранения в странах с высоким уровнем доходов, её трудно искоренить, и она стала неотложной проблемой для существующих хорошо развитых систем эпиднадзора. Кроме того, угроза устойчивости Campylobacter к антибиотикам растет с угрожающей скоростью. Причины, по которым Campylobacter поражает больше мужчин, чем женщин, а также возраст и географическое распространение инфекции ещё требуют тщательного исследования.
Список литературы
1. Kirk M.D., Pires S.M., Black R.E., Caipo M., Crump J.A., Devleesschauwer B., et al. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med. 2015; 12(12): e1001921. https://doi.org/10.1371/journal.pmed.1001921
2. Costa D., Iraola G. Pathogenomics of emerging Campylobacter species. Clin. Microbiol. Rev. 2019; 32(4): e00072-18. https://doi.org/10.1128/cmr.00072-18
3. Man S.M. The clinical importance of emerging Campylobacter species. Nat. Rev. Gastroenterol. Hepatol. 2011; 8(12): 669-85. https://doi.org/10.1038/nrgastro.2011.191
4. Kaakoush N.O., Castaño-Rodríguez N., Mitchell H.M., Man S.M. Global epidemiology of Campylobacter infection. Clin. Microbiol. Rev. 2015; 28(3): 687-720. https://doi.org/10.1128/cmr.00006-15
5. Nielsen H., Hansen K.K., Gradel K.O., Kristensen B., Ejlertsen T., Østergaard C., et al. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin. Microbiol. Infect. 2010; 16(1): 57-61. https://doi.org/10.1111/j.1469-0691.2009.02900.x
6. Kaakoush N.O., Castaño-Rodríguez N., Mitchell H.M., Man S.M. Global epidemiology of Campylobacter infection. Clin. Microbiol. Rev. 2015; 28(3): 687-720. https://doi.org/10.1128/cmr.00006-15
7. Man S.M. The clinical importance of emerging Campylobacter species. Nat. Rev. Gastroenterol. Hepatol. 2011; 8(12): 669-85. https://doi.org/10.1038/nrgastro.2011.191
8. Fitzgerald C. Campylobacter. Clin. Lab. Med. 2015; 35(2): 289-98. https://doi.org/10.1016/j.cll.2015.03.001
9. Scallan E., Hoekstra R.M., Angulo F.J., Tauxe R.V., Widdowson M.A., Roy S.L., et al. Foodborne illness acquired in the United States — major pathogens. Emerg. Infect. Dis. 2011; 17(1): 7-15.
10. European Food Safety Authority; European Centre for Disease Prevention and Control. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2016. EFSA J. 2017; 15(12): e05077. https://doi.org/10.2903/j.efsa.2017.5077
11. Gastrointestinal Infections Department. Campylobacter data 2007 to 2016. London: Public Health England; 2018. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/796964/campylo-bacter_data_2007_to_2016_may_2018.pdf
12. Nichols G.L., Richardson J.F., Sheppard S.K., Lane C., Sarran C. Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011. BMJ Open. 2012; 2(4): e001179. https://doi.org/10.1136/bmjopen-2012-001179
13. Schielke A., Rosner B.M., Stark K. Epidemiology of campylo-bacteriosis in Germany - insights from 10 years of surveillance. BMC Infect. Dis. 2014; 14: 30. https://doi.org/10.1186/1471-2334-14-30
14. Moffatt C.R., Glass K., Stafford R., D'Este C., Kirk M.D. The campylobacteriosis conundrum - examining the incidence of infection with Campylobacter sp. in Australia, 1998-2013. Epidemiol. Infect. 2017; 145(4): 839-47. https://doi.org/10.1017/s0950268816002909
15. Bassal R., Lerner L., Valinsky L., Agmon V., Peled N., Block C., et al. Trends in the Epidemiology of Campylobacteriosis in Israel (1999-2012). Foodborne Pathog. Dis. 2016; 13(8): 448-55. https://doi.org/10.1089/fpd.2015.2096
16. Geissler A.L., Bustos Carrillo F., Swanson K., Patrick M.E., Fullerton K.E., Bennett C., et al. Increasing Campylobacter infections, outbreaks, and antimicrobial resistance in the United States, 2004-2012. Clin. Infect. Dis. 2017; 65(10): 1624-31. https://doi.org/10.1093/cid/cix624
17. Kuhn K.G., Nielsen E.M., M0lbak K., Ethelberg S. Epidemiology of campylobacteriosis in Denmark 2000-2015. Zoonoses Public Health. 2018; 65(1): 59-66. https://doi.org/10.1111//ph.12367
18. Jeffs E., Williman J., Martin N., Brunton C., Walls T. Epidemiology of Campylobacter gastroenteritis in New Zealand children and the effect of the Campylobacter strategy: A 20-year observational study. Pediatr. Infect. Dis. J. 2019; 38(6): 569-76. https://doi.org/10.1097/inf.0000000000002228
19. O'Connor L., McKeown P., Barrasa A., Garvey P. Epidemiology of campylobacter infections in Ireland 2004-2016: What has changed? Zoonoses Public Health. 2020; 67(4): 362-9. https://doi.org/10.1111/zph.12695
20. Fish E.N. The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 2008; 8(9): 737-44. https://doi.org/10.1038/nri2394
21. Klein S.L. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci. Biobehav. Rev. 2000; 24(6): 627-38. https://doi.org/10.1016/s0149-7634(00)00027-0
22. Rizzetto L., Fava F., Tuohy K.M., Selmi C. Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex. J. Autoimmun. 2018; 92: 12-34. https://doi.org/10.1016/j.jaut.2018.05.008
23. Bertakis K.D., Azari R., Helms L.J., Callahan E.J., Robbins J.A. Gender differences in the utilization of health care services. J. Fam. Pract. 2000; 49(2): 147-52.
24. Simonsen J., Frisch M., Ethelberg S. Socioeconomic risk factors for bacterial gastrointestinal infections. Epidemiology. 2008; 19(2): 282-90. https://doi.org/10.1097/ede.0b013e3181633c19
25. Williams M.S., Golden N.J., Ebel E.D., Crarey E.T., Tate H.P. Temporal patterns of Campylobacter contamination on chicken and their relationship to campylobacteriosis cases in the United States. Int. J. Food Microbiol. 2015; 208: 114-21. https://doi.org/10.1016/j.ijfoodmicro.2015.05.018
26. Shen Z., Wang Y., Zhang Q., Shen J. Antimicrobial resistance in Campylobacter spp. Microbiol. Spectr. 2018; 6(2). https://doi.org/10.1128/microbiolspec.arba-0013-2017
Journal of microbiology, epidemiology and immunobiology. 2021; 98: 588-596
Epidemiologic characteristics of Campylobacter infections in high-income countries: a systematic review
https://doi.org/10.36233/0372-9311-167Abstract
Introduction. The Campylobacter is the most common bacterial cause of foodborne illnesses in high-income countries. In contrast to other infectious diseases, the number of Campylobacter cases has increased in developed countries over the last ten years. A systematic review has been conducted to identify the factors contributing to incidence of Campylobacter infection in developed countries and to estimate it by age, sex, geography, and season.
Materials and methods. The review was limited to studies published in English from 2010-2021; eight nationwide surveillance and register-based cohort studies, which met the selection criteria, were included in the review.
Results. While the highest incidence of Campylobacter infection was reported among young children living in rural areas, the highest number of Campylobacter cases among adults was recorded in urban settings. Nevertheless, population-wise, children and older adults are most affected, while the incidence rates are higher in males than in females, with cases peaking every summer.
Conclusion. Campylobacter infection is a public health concern in high-income countries, being difficult to eradicate and having become an urgent challenge to the existing well-developed surveillance systems. Additionally, the threat of antibiotic resistance in Campylobacter is growing at an alarming rate. The reasons behind Campylobacter affecting more men than women as well as the age and geographic distribution of the infection still need thorough research.
References
1. Kirk M.D., Pires S.M., Black R.E., Caipo M., Crump J.A., Devleesschauwer B., et al. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med. 2015; 12(12): e1001921. https://doi.org/10.1371/journal.pmed.1001921
2. Costa D., Iraola G. Pathogenomics of emerging Campylobacter species. Clin. Microbiol. Rev. 2019; 32(4): e00072-18. https://doi.org/10.1128/cmr.00072-18
3. Man S.M. The clinical importance of emerging Campylobacter species. Nat. Rev. Gastroenterol. Hepatol. 2011; 8(12): 669-85. https://doi.org/10.1038/nrgastro.2011.191
4. Kaakoush N.O., Castaño-Rodríguez N., Mitchell H.M., Man S.M. Global epidemiology of Campylobacter infection. Clin. Microbiol. Rev. 2015; 28(3): 687-720. https://doi.org/10.1128/cmr.00006-15
5. Nielsen H., Hansen K.K., Gradel K.O., Kristensen B., Ejlertsen T., Østergaard C., et al. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin. Microbiol. Infect. 2010; 16(1): 57-61. https://doi.org/10.1111/j.1469-0691.2009.02900.x
6. Kaakoush N.O., Castaño-Rodríguez N., Mitchell H.M., Man S.M. Global epidemiology of Campylobacter infection. Clin. Microbiol. Rev. 2015; 28(3): 687-720. https://doi.org/10.1128/cmr.00006-15
7. Man S.M. The clinical importance of emerging Campylobacter species. Nat. Rev. Gastroenterol. Hepatol. 2011; 8(12): 669-85. https://doi.org/10.1038/nrgastro.2011.191
8. Fitzgerald C. Campylobacter. Clin. Lab. Med. 2015; 35(2): 289-98. https://doi.org/10.1016/j.cll.2015.03.001
9. Scallan E., Hoekstra R.M., Angulo F.J., Tauxe R.V., Widdowson M.A., Roy S.L., et al. Foodborne illness acquired in the United States — major pathogens. Emerg. Infect. Dis. 2011; 17(1): 7-15.
10. European Food Safety Authority; European Centre for Disease Prevention and Control. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2016. EFSA J. 2017; 15(12): e05077. https://doi.org/10.2903/j.efsa.2017.5077
11. Gastrointestinal Infections Department. Campylobacter data 2007 to 2016. London: Public Health England; 2018. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/796964/campylo-bacter_data_2007_to_2016_may_2018.pdf
12. Nichols G.L., Richardson J.F., Sheppard S.K., Lane C., Sarran C. Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011. BMJ Open. 2012; 2(4): e001179. https://doi.org/10.1136/bmjopen-2012-001179
13. Schielke A., Rosner B.M., Stark K. Epidemiology of campylo-bacteriosis in Germany - insights from 10 years of surveillance. BMC Infect. Dis. 2014; 14: 30. https://doi.org/10.1186/1471-2334-14-30
14. Moffatt C.R., Glass K., Stafford R., D'Este C., Kirk M.D. The campylobacteriosis conundrum - examining the incidence of infection with Campylobacter sp. in Australia, 1998-2013. Epidemiol. Infect. 2017; 145(4): 839-47. https://doi.org/10.1017/s0950268816002909
15. Bassal R., Lerner L., Valinsky L., Agmon V., Peled N., Block C., et al. Trends in the Epidemiology of Campylobacteriosis in Israel (1999-2012). Foodborne Pathog. Dis. 2016; 13(8): 448-55. https://doi.org/10.1089/fpd.2015.2096
16. Geissler A.L., Bustos Carrillo F., Swanson K., Patrick M.E., Fullerton K.E., Bennett C., et al. Increasing Campylobacter infections, outbreaks, and antimicrobial resistance in the United States, 2004-2012. Clin. Infect. Dis. 2017; 65(10): 1624-31. https://doi.org/10.1093/cid/cix624
17. Kuhn K.G., Nielsen E.M., M0lbak K., Ethelberg S. Epidemiology of campylobacteriosis in Denmark 2000-2015. Zoonoses Public Health. 2018; 65(1): 59-66. https://doi.org/10.1111//ph.12367
18. Jeffs E., Williman J., Martin N., Brunton C., Walls T. Epidemiology of Campylobacter gastroenteritis in New Zealand children and the effect of the Campylobacter strategy: A 20-year observational study. Pediatr. Infect. Dis. J. 2019; 38(6): 569-76. https://doi.org/10.1097/inf.0000000000002228
19. O'Connor L., McKeown P., Barrasa A., Garvey P. Epidemiology of campylobacter infections in Ireland 2004-2016: What has changed? Zoonoses Public Health. 2020; 67(4): 362-9. https://doi.org/10.1111/zph.12695
20. Fish E.N. The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 2008; 8(9): 737-44. https://doi.org/10.1038/nri2394
21. Klein S.L. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci. Biobehav. Rev. 2000; 24(6): 627-38. https://doi.org/10.1016/s0149-7634(00)00027-0
22. Rizzetto L., Fava F., Tuohy K.M., Selmi C. Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex. J. Autoimmun. 2018; 92: 12-34. https://doi.org/10.1016/j.jaut.2018.05.008
23. Bertakis K.D., Azari R., Helms L.J., Callahan E.J., Robbins J.A. Gender differences in the utilization of health care services. J. Fam. Pract. 2000; 49(2): 147-52.
24. Simonsen J., Frisch M., Ethelberg S. Socioeconomic risk factors for bacterial gastrointestinal infections. Epidemiology. 2008; 19(2): 282-90. https://doi.org/10.1097/ede.0b013e3181633c19
25. Williams M.S., Golden N.J., Ebel E.D., Crarey E.T., Tate H.P. Temporal patterns of Campylobacter contamination on chicken and their relationship to campylobacteriosis cases in the United States. Int. J. Food Microbiol. 2015; 208: 114-21. https://doi.org/10.1016/j.ijfoodmicro.2015.05.018
26. Shen Z., Wang Y., Zhang Q., Shen J. Antimicrobial resistance in Campylobacter spp. Microbiol. Spectr. 2018; 6(2). https://doi.org/10.1128/microbiolspec.arba-0013-2017
